Circulating IGFBP-2 levels are inversely associated with the incidence of nonalcoholic fatty liver disease: A cohort study.
Ji YangWenjing ZhouYue WuLiqian XuYuming WangZherong XuYun-Mei YangPublished in: The Journal of international medical research (2021)
These results indicate that IGFBP-2 levels are inversely associated with the risk of NAFLD. This offers new insights into the role of circulating IGFBP-2, as an IGF-axis hepatokine, in the pathogenesis of hepatic steatosis.
Keyphrases